SCHEMBL38652154

SCHEMBL38652154

CC(C)(C)OC(=O)N1CCCC[C@@H]1c1cc(Br)ccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
OPRK1 P41145 1/20 0.44
TSHR P16473 4/20 0.43
LMNA P02545 4/20 0.43
NPSR1 Q6W5P4 2/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43
USP30 Q70CQ3 1/20 0.42
NR1H2 P55055 2/20 0.41
NR1H3 Q13133 1/20 0.41
UCHL1 P09936 1/20 0.41
EPHA2 P29317 1/20 0.40
KDR P35968 1/20 0.40
EPHB4 P54760 1/20 0.40
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31472404 0.86 TSHR (0.40) ALDH1A1KMT2AMEN1RAB9ASMN1; SMN2
SCHEMBL21491244 0.86 TSHR (0.40) ALDH1A1KMT2AMEN1RAB9ASMN1; SMN2
SCHEMBL38652267 0.84 OPRK1 (0.45) ALDH1A1KMT2AMEN1OPRK1TSHR
SCHEMBL22820439 0.83 USP30 (0.46) ALDH1A1KMT2ATSHRLMNANPSR1
SCHEMBL14757730 0.82 KMT2A (0.45) ALDH1A1KMT2AMEN1TSHRLMNA
SCHEMBL13154983 0.82 KMT2A (0.45) ALDH1A1KMT2AMEN1TSHRLMNA
SCHEMBL890187 0.82 KMT2A (0.45) ALDH1A1KMT2AMEN1TSHRLMNA
SCHEMBL13740383 0.81 LMNA (0.48) ALDH1A1KMT2ATSHRLMNANPSR1
SCHEMBL38652319 0.81 NR1H2 (0.37) ALDH1A1KMT2AMEN1OPRK1TSHR
SCHEMBL28448215 0.80 NR1H2 (0.53) ALDH1A1KMT2ALMNANPSR1USP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122010910-A Biazacycloalkane Menin-MLL protein inhibitor, pharmaceutical composition and application thereof 赛诺哈勃药业(成都)有限公司 2026-05-12 CN disclosed